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Abstract
Residue Arg3.50 belongs to the highly conserved DRY-motif of class A GPCRs, which is
located at the bottom of TM3. On the one hand, Arg3.50 has been reported to help stabilize
the inactive state of GPCRs, but on the other hand has also been shown to be crucial for
stabilizing active receptor conformations and mediating receptor-G protein coupling. The
combined results of these studies suggest that the exact function of Arg3.50 is likely to be
receptor-dependent and must be characterized independently for every GPCR. Conse-
quently, we now present comparative molecular-dynamics simulations that use our recently
described inactive-state and Gα-bound active-state homology models of the dopamine D2
receptor (D2R), which are either bound to dopamine or ligand-free, performed to identify the
function of Arg1323.50 in D2R. Our results are consistent with a dynamic model of D2R acti-
vation in which Arg1323.50 adopts a dual role, both by stabilizing the inactive-state receptor
conformation and enhancing dopamine-dependent D2R-G protein coupling.
Introduction
Residue Arg3.50 (the superscript refers to the generic Ballesteros-Weinstein numbering[1])
belongs to the DRY-motif of G protein-coupled receptors (GPCRs), which is located at the
base of transmembrane helix (TM) 3, and had been suggested to play a vital role in regulating
the structure and function of these receptors.[2] The individual residues of the DRY-motif,
aspartate (or glutamate), arginine and tyrosine, are highly conserved among class A GPCRs;
their degree of conservation is 67.9% (D)/22.8% (E), 96.8% and 71.5%, respectively (calculated
by means of the GMOS web interface, http://lmc.uab.cat/gmos/cgmos.php).
Arg3.50 is part of the so-called ionic lock, an intramolecular ionic interaction between
Arg3.50 of TM3 and Glu6.30 of TM6, which was originally observed in the crystal structure of
dark-state rhodopsin.[3] As alanine mutation of Glu6.30 has been shown to enhance constitu-
tive activity at the β2 adrenergic receptor (β2AR), the ionic lock was suggested to help stabilize
PLOSONE | DOI:10.1371/journal.pone.0146612 January 7, 2016 1 / 13
a11111
OPEN ACCESS
Citation: Kling RC, Clark T, Gmeiner P (2016)
Comparative MD Simulations Indicate a Dual Role for
Arg1323.50 in Dopamine-Dependent D2R Activation.
PLoS ONE 11(1): e0146612. doi:10.1371/journal.
pone.0146612
Editor: Debra Kendall, University of Connecticut,
UNITED STATES
Received: July 21, 2015
Accepted: December 18, 2015
Published: January 7, 2016
Copyright: © 2016 Kling et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: The authors have no support or funding to
report.
Competing Interests: The authors have declared
that no competing interests exist.
the ground state of GPCRs.[4, 5] With the exception of rhodopsin,[3] the dopamine D3 recep-
tor (D3R) [6] and distinct β1 adrenergic receptor (β1AR)-ligand combinations,[7] an intact
ionic lock is not observed within the majority of currently available crystal structures. However,
several independently performed molecular-dynamics (MD) simulations have reported the
highly dynamic nature of this interaction, with an equilibrium between intact and broken
ionic-lock conformations, which is likely to reflect the basal activity of non-rhodopsin GPCRs.
[5, 8–10] The existence of open and closed states of the ionic lock, connected to different con-
formations of TM6, had been supported by crystal structures of β1AR.[7] Nevertheless, only
34% (calculated by means of the GMOS web interface, http://lmc.uab.cat/gmos/cgmos.php) of
class A GPCRs exhibit both an arginine and a glutamate residue at positions 3.50 of TM3 and
6.30 of TM6, respectively. This suggests that an intact ionic lock may not be the only determi-
nant that stabilizes inactive-state GPCRs. Thus, it was not possible to reduce the pronounced
constitutive activity of the wild-type histamine H4 receptor (H4R), which has an alanine resi-
due in position 6.30, when trying to reconstitute the possibility of forming an ionic interaction
to Arg3.50 using an Ala6.30Glu mutant receptor.[11]
Besides its (possible) contribution to the basal signaling profile of GPCRs, the crystal struc-
ture of opsin in complex with the C-terminal fragment of transducin revealed hydrogen bonds
between the side chain of Arg3.50 and that of Tyr5.58 of TM5. Arg3.50 also hydrogen bonds to
the backbone carbonyl atom of Cys347 of the G protein, thus attributing a key role to Arg3.50 in
stabilizing active-state GPCR conformations and mediating receptor-G protein interactions.
[12] Based on this structure, we recently performed computational studies on β2AR together
with the C-terminal fragment of Gαs, in which direct interactions between Arg
3.50 and residues
of the G protein could be observed.[13] The crystal structure of β2AR coupled to the heterotri-
meric Gs protein confirmed such direct interactions: the side chain of Arg3.50 was found to
pack against Tyr391 of Gαs.[14] In addition, MD simulations on our previously developed
homology model of the dopamine D2 receptor (D2R)-Gαi complex indicated an ionic interac-
tion of Arg1323.50 and a C-terminal residue Asp350 of Gαi.[15] This ionic interaction was
found to persist in the presence of the full agonist dopamine, but to be destabilized by aripipra-
zole-type partial agonists.[16] In agreement with these studies, different groups have reported
reduced or abolished G-protein activation when Arg3.50 of wild-type receptors is mutated to
alanine, including D2R,[17] rhodopsin[18] and H4R.[11] In addition, it was shown that muta-
tions of Arg3.50 that cause a loss of the capacity to couple to or to activate G proteins can culmi-
nate in diseases such as autosomal dominant retinitis pigmentosa (ADRP),[18] nephrogenic
diabetes insipidus[19] or hypogonadotropic hypogonadism.[20] However, no unified picture
of the influence of Arg3.50 on G protein activation can be generated, as, for example, different
mutations of Arg3.50 at β2AR were connected to an unchanged ability to activate Gαs (even if
the capacity to recruit β-arrestin was reduced for the Arg3.50Ala mutant).[5, 21] A more
detailed discussion of the effect of distinct Arg3.50 mutations at different receptors is provided
in the literature.[2]
Taken together, these results suggest that the exact function of Arg3.50 is likely to be recep-
tor-dependent and must be characterized independently for every GPCR. As (I) D2R exhibits
both residues Arg1323.50 and Glu3686.30, and is thus, in principal, competent to form an ionic
lock interaction, and (II) previous studies on the (dopamine-bound) D2R-Gαi complex sug-
gested a direct ionic interaction between Arg1323.50 and the G protein,[15, 16] we chose to
investigate these interactions for inactive- and active-state D2R conformations. Therefore,
while taking advantage of the recent developments in the structural determination of GPCRs, a
comparative analysis of MD simulations that use our inactive-state[22] and active-state homol-
ogy models of D2R,[15] both bound to dopamine or ligand-free (apo), was performed to iden-
tify the function of Arg1323.50 at D2R.
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Results/Discussion
Stability of the Simulation Systems
Eleven individual long-termMD simulations were performed on homology models of D2R,
which were either coupled to dopamine, (and/or) Gαi or did not contain an additional binding
partner (Fig 1). Data derived from previous MD simulations on a dopamine-bound D2R-Gαi
complex were used for comparison (system D1). The overall conformational stability of the dif-
ferent complexes was found to be sufficient for subsequent analyses, as indicated by RMSD
analysis of the individual members of the simulation systems (S1 Fig), which did not undergo
destructive conformational changes that affected the integrity of the complexes. Within the
Gαi-bound systems (complexes C1, C2 and D2), higher mobility was observed for Gαi than for
the receptor (in particular, the helical subdomain of the Gαi-subunit (GαiAH), S2 Fig), which
is in agreement with our previous studies on ternary complexes,[15, 16] and, as previously, Gαi
did not show any tendency to separate from active-state D2R (S3 Fig). Importantly, the global
conformational state of the receptors (either inactive- or active-state like) did not change
throughout the simulation time, as determined by measuring the distances between the intra-
cellular tips of TM3 and TM6 (Fig 2). In the course of this study, the active-state of D2R is
characterized by the outward movement of TM6 and the presence of the Gαi-subunit of the G
protein (systems C and D), whereas the inactive-state systems lack the latter features (systems
A and B). Visual comparison of several overlaid average structures of systems A-D derived
from different time windows along the simulation pathways indicated that the presence of
dopamine in the systems B and D was associated with a reduced mobility of extracellular recep-
tor domains compared to the apo-simulations. This stabilizing effect was significantly more
pronounced in the active-state simulations C and D (S4 Fig). Moreover, the presence of dopa-
mine was found to increase the conformational stability of the outward movement of TM6 in
the absence of the G protein (S5 Fig).
Analysis of Dopamine Binding at Inactive- and Active-State D2R Models
Within the dopamine-bound systems B and D, dopamine was found to occupy, as expected,
the same orthosteric binding pocket throughout the MD simulations in both the inactive- and
active-state D2R, and to adopt a similar conformation therein (Fig 3A and 3B). The conforma-
tion of dopamine is stabilized by hydrogen bonds between its catechol moiety and Ser1935.42
and Ser1975.46 of TM5 and His3936.55 of TM6 (not shown), all of which are in agreement with
previous studies reporting their importance for the binding of dopamine.[23, 24] In addition,
Fig 1. Schematic overview of the main simulation systems and their simulation times. To visually help
distinguish the apo- (in which dopamine is absent, A and C) from the dopamine-bound complexes (dopamine
in orange, B and D), TM 1, 2 and 7 are colored in light-grey and dark-grey, respectively. For clarity, TM3 and
TM6 are colored in light-blue and dark-blue, respectively. The active-state systems (C and D) are
represented by the characteristic outward movement of TM6 and the presence of Gαi (in green). The asterisk
refers to a previously published simulation. The simulation times of each system are given in bold.
doi:10.1371/journal.pone.0146612.g001
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the canonical salt bridge between the protonated amine moiety of dopamine and Asp1143.32 of
TM3 was formed persistently, an interaction that has been shown to be an irreplaceable prereq-
uisite for specific ligand binding at dopaminergic receptors.[25] Although the presence of Gαi
did not significantly alter the nature and occurrence of intermolecular interactions between
dopamine and D2R relative to inactive-state D2R, a slightly reduced dopamine mobility and an
increase of 4.8 kcal/mol in its binding energy were observed (Fig 3A and 3B, S6 Fig). These
observations are obviously the consequence of different shapes of the extracellular surface
above the binding pocket of D2R (measured as the distance between Ile183 of extracellular
loop 2 (EL2) and Tyr4087.35 of TM7, S7 Fig). A persistently closed conformation around the
agonist dopamine was found in simulations of the fully active ternary signaling complex, thus
facilitating the stabilization of dopamine (Fig 3C and 3D). A closed structure above the binding
pocket of dopamine was originally observed in previous simulations of system D1,[16] and
could now be confirmed by an additional MD simulation (system D2). Increased distances
between EL2 and the upper part of TM7 associated with an open binding pocket to the extra-
cellular surface were observed in both apo-D2R simulations (S4 and S7 Figs). The observation
that neither the presence of dopamine (system B) nor of Gαi alone (system C, representing the
basally-active signaling state of D2R) were sufficient to result in a persistent and stable
Fig 2. Conformational classification of the simulation systems A-D. (A, B) Intracellular view on cytoplasmic receptor domains of the simulations systems
A-D indicating unchanged global conformational states throughout the MD simulations: An overlay of average structures of representative simulation
systems (each derived from the final 25ns simulation times) is shown for (A) inactive-state systems A (light-grey) and B (light-orange) and (B) the active-state
systems C (dark-grey) and D (brown). For comparison, the X-ray structures of inactive-state D3R (blue) and active-state β2AR (green), which were used for
homology modeling, are depicted. (C, D) The distances (and occurrences of these distances) between the intracellular ends of TM3 and TM6, measured as
the distances between the Cα-atoms of Arg1323.50 and Glu3686.30, are shown for (C) the inactive-state systems A and B and (D) the active-state systems C
and D. For comparison, these distances at crystal structures of D3R and β2AR are highlighted with dashed lines. Colors are used as described above.
doi:10.1371/journal.pone.0146612.g002
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contraction of extracellular domains near the binding pocket supports observations that both
agonists and an intracellular binding partner are required to capture fully active-state confor-
mations of GPCRs,[26, 27] including those of active-state binding pockets. However, the possi-
bility that such contractions would eventually be triggered on much longer time-scales cannot
be excluded.
Dopamine-Binding at Inactive-State D2R Reduces the Stability of the
Ionic Lock
The overall aim of this study was to identify the function of Arg1323.50 in the pharmacologi-
cally relevant D2R, which includes in particular the investigation whether or not an intramo-
lecular ionic interaction to Glu3686.30 at the inactive-state receptor can be formed, thus
stabilizing the ground-state of D2R, and whether this ionic interaction can be modulated by
the presence of the endogenous agonist dopamine. Consequently, this chapter will focus on the
analysis of 4 μs MD simulations at inactive-state D2R, which were performed under two differ-
ent conditions: ligand-free (apo, system A) or bound to dopamine (system B).
Fig 3. Overview of the binding pockets of dopamine at the simulations systems B and D. (A, B) Side view of representative average structures derived
from different time points along the MD simulation pathways, focusing on the binding pockets of dopamine (orange) at inactive-state (system B, ocher) and
active-state (system D, brown) D2R. TM6 has been removed for clarity. In each complex, dopamine is stabilized by hydrogen bonds to Ser1935.42 and
Ser1975.46 and by an ionic interaction to Asp1143.32, but shows a slightly higher mobility at inactive-state D2R (system B). (C, D) Top view onto the binding
pockets of representative snapshots of the systems B1 (ocher) and D1 (brown). Each structure is derived from the final 25ns of simulation time. Dopamine is
shown as orange spheres. In system B1, the binding pocket is open to the extracellular surface of D2R, showing a large distance between Ile183EL2 and
Tyr4087.35 (indicated in red), whereas the binding pocket in system D1 is closed to the extracellular surface by these residues approaching each other.
doi:10.1371/journal.pone.0146612.g003
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In general, our results indicate that the inactive-state of D2R is able to adopt both formed (=
closed) and broken (= open) conformations of the ionic lock, which were found to exist in
dynamic equilibrium with each other (Fig 4A). These observations are in excellent agreement
with previous MD simulations on closely related adrenergic receptors, which had reported
alternately open and closed conformations of the ionic lock.[5, 8, 9] At β1AR, it was even possi-
ble to crystallize the different states of this motif, where such structural plasticity of intracellu-
lar receptor domains had been suggested to be a general feature of non-rhodopsin GPCRs,
which exhibit varying capacities for ligand-independent signaling (also referred to as basal
activity).[7] The evolution of side-chain distances between Arg1323.50 (Cz) of TM3 and
Glu3686.30 (Cδ) of TM6 revealed that in MD simulations of the apo D2R-system A (represent-
ing the ligand-free ground state of D2R), the formation of an intact ionic lock between these
residues is highly favored (Fig 4B). Thus, in the absence of an agonist, the ionic lock was closed
most of the time, which is likely to help stabilize the inactive, ground state conformation of
D2R. The latter assumption is supported by previous MD simulations studies on both carazo-
lol-bound and apo β2AR, demonstrating that the extent of ionic-lock formation in the presence
of the inverse agonist carazolol, which is known to stabilize the inactive-state of β2AR, is
unchanged when compared to the ligand-free β2AR system.[8] In contrast, we observed that
the presence of the endogenous agonist dopamine (system B) significantly reduced the occur-
rence of an intact ionic lock (Fig 4C), which is likely to result in an impaired capacity of this
intramolecular interaction to stabilize the inactive-state of D2R. A comparable, agonist-depen-
dent decreasing effect on the frequency of ionic-lock conformations was also suggested by MD
simulations at the 5-HT2A receptor.[10] In addition to the enhanced probability of encounter-
ing a broken ionic lock, we found that in the presence of dopamine, conformations featuring
distances larger than 9.5 Å between the intracellular ends of TM3 and TM6 (measured as the
Cα-distance of Arg1323.50 and Glu3686.30, Fig 2), were increased compared to the ligand-free
Fig 4. Distances of ionic lock residues at the inactive-state systems A and B. (A) Close view on representative conformations of an intact (= closed,
grey) and a broken (= open, orange) ionic lock between residues Arg1323.50 of TM3 (light-blue) and Glu3686.30 of TM6 (dark-blue). In addition, Arg1323.50 is
stabilized by Asp1313.49 of TM3. (B, C) Distances between the side chains of residues Arg1323.50 (Cζ) and Glu3686.30 (Cδ) in the course of the simulations A
and B are shown. Cumulative occurrences of certain distances for system A (B) predominantly show distances, which are consistent with an intact ionic lock
(green boxes). In contrast, the latter distances are less frequently populated at the dopamine-bound system B (C), when higher occurrences were observed
for larger distances, consistent with an open ionic lock.
doi:10.1371/journal.pone.0146612.g004
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system A (Fig 5). Distances larger than 9.5 Å were previously shown to be associated with bro-
ken ionic lock conformations by MD simulations and crystal structures.[8, 9] The separation
of TM3 and TM6 is associated with an outward movement of TM6, which represents a major
hallmark of GPCR activation.[28] However, additional simulations are needed to increase the
statistical significance of the result shown in Fig 5.
Taken together, our results are consistent with a structural mechanism of dopamine-depen-
dent D2R activation, by which the agonist dopamine reduces the stability of the ionic lock,
thereby reducing the global conformational stability of the inactive-state of D2R, and thus
increases the probability for an outward movement of TM6, which finally facilitates receptor
activation. It is important to note that even in the absence of dopamine (system A), we detected
open ionic lock conformations and a minor fraction of TM6 showing limited outward move-
ment, both of which are consistent with the basal activity profile of D2R. Although we are
aware that there may also be other intramolecular interactions that stabilize the inactive-state
of D2R, it is tempting to assume that the breakage of the ionic lock is one crucial and necessary
prerequisite in the activation process of D2R.
Dopamine Binding at Active-State D2R-Gαi Complexes Triggers the
Formation of an Ionic Interaction between D2R and Gαi via Arg132
3.50
Crystal structures of opsin and β2AR coupled to the C-terminal fragment of transducin and
the natural Gs protein, respectively, revealed direct interactions of receptors and G proteins,
which were, among others, mediated by residue Arg3.50 of the receptors.[12, 14] The structures
supported various experiments employing Arg3.50 receptor mutants, which had attributed a
key role to this residue in maintaining the active-state of a GPCR.[2] In addition, by using
long-term MD simulations on a dopamine-bound ternary D2R-Gαi complex model based on
the crystal structure of β2AR coupled to Gαs,[15] we previously detected a consistent ionic
interaction between Arg1323.50 of D2R and Asp350 of Gαi, which we suggested to help stabilize
receptor-G protein coupling.[16] The latter observation is supported by experiments using an
Fig 5. Total occurrences of distances larger than 9.5 Å between Arg1323.50 and Glu3686.30 at the
simulation systems A and B. The fractions of simulation time within the systems A and B, in which the
distances between the Cα-atoms of Arg1323.50 and Glu3686.30 were found to be larger than 9.5 Å. The values
above the bars represent mean ± standard error of the mean of the simulation systems A and B and indicate a
higher frequency of distances larger than 9.5 Å in the presence of dopamine (unpaired t-test, two-tailed P
value = 0.0960).
doi:10.1371/journal.pone.0146612.g005
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Arg1323.50Ala mutant of D2R, which completely lost the capacity to activate G proteins upon
agonist stimulation.[17] As the final part of this study, which was designed to investigate the
function of Arg1323.50 in both inactive- and active-state conformations of D2R, we now focus
on the analysis of the structural properties of this latter ionic interaction, employing a total of
3.9 μs MD simulations performed on either dopamine-bound (system D) or ligand-free (sys-
tem C) D2R-Gαi models.
We detected the formation of a consistent ionic interaction between Arg1323.50 of D2R and
Asp350 of Gαi after approximately 200 ns in the presence of dopamine. This was further cor-
roborated by an additional MD simulation run on the same dopamine-bound ternary D2R-Gαi
complex (system D2), in which this ionic interaction was formed reproducibly and remained,
in both cases, stable for most of the simulation time (Fig 6B). In the absence of dopamine (sys-
tem C), increasing distances between the corresponding residues Arg1323.50 of D2R and
Asp350 of Gαi were observed in two independent simulation runs on the same apo D2R-Gαi
complex, indicating that the aforementioned ionic interaction can hardly be formed in the
ligand-free, basally active-state of D2R (Fig 6A). It is thus tempting to speculate that Arg1323.50
may play a crucial role in mediating a ligand-induced increase in G protein activation.
Interestingly, these results show that a valid answer whether or not an ionic interaction
between Arg1323.50 and Asp350 can be formed in the particular simulation systems C1 and C2
does not become evident before a certain “induction period”, in these large systems of more
than 200,000 atoms at least 200 ns (Fig 6). This is in line with ten individual MD simulations
on system C (systems C3 to C12), each using the same configuration than C1 and C2, ran-
domly attributed initial velocities and each lasting 100 ns, which do not show a clear tendency
of the system to form an ionic interaction between Arg1323.50 and Asp350 (S8 Fig). These
Fig 6. Time evolution of the ionic interaction between D2R and Gαi at the active-state systems C and D. Representative snapshots of ligand-free (A,
top line) and dopamine-bound (B, top line) active-state D2R conformations, showing an either broken or formed ionic interaction between residues
Arg1323.50 of D2R and Asp350 of Gαi, respectively. In addition, the time evolution of distances between Arg132
3.50 (Cζ) of D2R and Asp350 (Cγ) of Gαi in
simulation systems C (A, bottom line) and D (B, bottom line) are depicted, revealing that distances, which allow the ionic interaction between D2R and Gαi
(green boxes) are only formed in the presence of dopamine.
doi:10.1371/journal.pone.0146612.g006
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observations support previous studies,[13, 15, 16, 29] in which our group has performed few
long simulations, rather than multiple shorter ones, in order “to avoid missing conformational
changes that occur with a characteristic induction period”.[16]
In summary, our analyses of MD simulations on the active-state systems C and D demon-
strate that the ionic interaction between D2R and Gαi strongly depends on the presence of an
agonist like dopamine. Only in the presence of dopamine (system D, Fig 6B) does this interac-
tion remain stable throughout the simulation time. We previously observed a reduced stability
of this particular ionic interaction once the full agonist dopamine was replaced by aripiprazole-
type partial agonists.[16] As agonists are known to enhance the capacity of GPCRs to activate
G proteins according to their distinct intrinsic efficacies,[30] we suggest that, at least in the case
of the D2R- Gαi complex, an agonist-dependent increase in the capacity of D2R to form an
ionic interaction to Gαi via Arg132
3.50 provides one structural explanation for the question as
to how this enhanced activation can be accomplished.
Conclusion
To identify the function of Arg1323.50 at D2R in terms of forming the intramolecular ionic lock
between TM3 and TM6 and an ionic interaction to the G protein, comparative MD simulations
on both inactive-state and Gα-bound active-state D2R models, which were either ligand-free
or bound to the endogenous agonist dopamine (Fig 1), were used.
Within the dopamine-bound systems B and D, our MD simulations detected different con-
formations of the extracellular surface above the binding pocket adopting a closed conforma-
tion in the fully activated Gα-bound system D (Fig 3), although the interactions of dopamine
with residues of D2R were comparable for active- and inactive-state D2R. As a result of MD
simulations on the inactive-state of D2R, we found that dopamine was able to attenuate ionic-
lock formation between Arg1323.50 of TM3 and Glu3686.30 of TM6 compared to the ligand-free
system (Fig 4). As a consequence, higher occupancies of increased distances between the intra-
cellular ends of TM3 and TM6 were recorded in the presence of dopamine, which are consis-
tent with a more pronounced outward movement of TM6 (Fig 5). Both of these observations
are in full agreement with the ability of dopamine to trigger D2R activation. Conducting MD
simulations that used the D2R-Gαi complexes, we observed a consistent ionic interaction
between Arg1323.50 of D2R and Asp350 of Gαi in the presence of dopamine, which was not
formed within the apo simulation (Fig 6), and which we believe is one structural explanation
for an enhanced G protein activation of agonist-bound D2R.
Taken together, our results lead to a model of D2R activation, in which Arg1323.50 partici-
pates in this process by adopting a dual role, both by the stabilization of the inactive-state
receptor conformation and by enhancing dopamine-dependent D2R-G protein coupling (Fig
7). Although it is still not possible to capture the activation process of GPCRs in a single trajec-
tory using classical MD simulations, this study provides a firm, dynamic model for dopamine-
dependent D2R activation.
Materials and Methods
A schematic overview of the simulation systems and their simulation times is shown in S1
Table. In general, comparative MD simulations on either dopamine-bound or ligand-free
homology models of inactive-state D2R and of the active-state D2R-Gαi1 complex, which were
based on the crystal structures of D3R[6] (PDB-ID: 3PBL) and β2AR-Gαs[14] (PDB-ID:
3SN6), respectively, were performed. The homology models were generated as described previ-
ously for inactive-state D2R[22] and the active-state complex.[15] Docking of dopamine was
performed manually as described.[15] The systems A, B and C were submitted to twenty
Role of Arg1233.50 in D2R Activation
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independent MD simulation runs ranging from 100 ns to 750 ns, and complemented by one
additional simulation run of 400 ns for complex D2 (Fig 1). The systems E and F were gener-
ated by removing Gαi from the final snapshots of the simulation systems C1 and D2, respec-
tively. Subsequently, two independent simulation runs for system E (850 ns and 700 ns) and F
(1050 ns and 1100 ns) were performed. All systems were embedded in a lipid bilayer consisting
of dioleoylphosphatidylcholine (DOPC) molecules as described.[15, 31] For comparison, the
results of previously published long-termMD simulations on the D2R-Gαi complex in pres-
ence of the full agonist dopamine were used (simulation D1).[15, 16]
To carry out MD simulations, the GROMACS simulation package was used as described
previously.[13] Briefly, the general AMBER force field (GAFF)[32] was used for dopamine and
the lipids and the AMBER force field ff99SB[33] for D2R and Gαi. The SPC/E water model[34]
was used, and the simulations were carried out at 310 K. In the absence of Gαi, no external
force was applied (systems A and B); in contrast, a stabilizing force (1.0 kcal mol-1 Å-2) was
applied to the N-terminal tail of the αN-helix of Gαi (systems C and D2). We removed water
and DOPC molecules for data analysis. The analysis of the trajectories was performed with the
PTRAJ module of AMBER10[35]. Figures were prepared using PyMOL[36] and Chimera[37].
Supporting Information
S1 Fig. RMS-deviations of the simulation systems. RMSD analyses in the course of the simu-
lation times for individual components of the systems A (A), B (B), C (C) and D (D) are
shown, revealing, in general, stable simulation systems. Dopamine and D2R are fitted on the
Cα-atoms of D2R, whereas Gαi is fitted on the Cα-atoms of Gαi. For the D2R-Gαi complexes
(C and D), coordinates are fitted on the Cα-atoms of D2R.
(TIFF)
S2 Fig. Atomic fluctuations within the simulation systems C1, C2 and D2. Atomic fluctua-
tions for the Cα-atoms of the systems C1 (A), C2 (B) and D2 (C) are shown, which had been cal-
culated as B-factors. The values are measured based on a fit to the Cα-atoms of the D2R-part of
the complexes.
(TIFF)
Fig 7. Concludingmodel of the predicted impact of Arg1323.50 on dopamine-dependent activation of
D2R. At the inactive-state system (left row), an equilibrium between a formed and a broken ionic lock was
observed, whereas the presence of dopamine was found to reduce the stability of the ionic lock. At active-
state D2R (right row), dopamine increased receptor-G protein interactions via the formation of an ionic
interaction between Arg1323.50 of D2R and Asp350 of Gαi. For clarity, TM3 and TM6 are colored in light-blue
and dark-blue, respectively.
doi:10.1371/journal.pone.0146612.g007
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S3 Fig. Distances between D2R and the C-termini of Gαi for the systems C1, C2 and D2.
Distances between the centers of mass of D2R and the C-termini of Gαi for the simulation sys-
tems C1 and C2 (A) and D2 (B) are shown.
(TIFF)
S4 Fig. Overlay of average structures of the simulation systems focusing on the extracellular
domains of D2R. Top view on the extracellular surface of the D2R units. For clarity, TM3 is
shown in blue. The average structures are calculated after the time points concretized above.
Dopamine (orange, right row) was found to stabilize extracellular receptor domains compared
to the apo systems (left row), which is more pronounced at active-state D2R (bottom line). Res-
idues of D2R (Ile183EL2 and Tyr4087.35) forming a lid over the binding pocket in system D are
highlighted in red.
(TIFF)
S5 Fig. Evolution of distances between TM3 and TM6 at the simulation systems E and F.
The distances between the intracellular ends of TM3 and TM6 (measured as the distances
between the Cα-atoms of Arg1323.50 and Glu3686.30) are shown for system E (A) and system F
(B). Mean values derived from the corresponding distances at simulation systems A-D are
highlighted with dashed lines. In both systems E and F, the G protein was removed. Our results
indicate a higher stability of the outward movement of TM6 in the presence of dopamine.
(TIFF)
S6 Fig. Atomic fluctuations and free energy of binding for dopamine at the simulation sys-
tems B and D. (A) Atomic fluctuations (calculated as B-factors after a fit on the Cα-atoms of
the coordinates of D2R) for the dopamine-bound systems B and D are shown. The values
above the bars represent the average fluctuation of the individual simulations 1 and 2. (B) Free
energy of binding calculations were performed for dopamine-binding at the simulation systems
B and D using the GBSA-Method. The numbers below the bars represent average values of
each simulation system and indicate an increased binding energy of 4.8 kcal/mol in the pres-
ence of Gαi (system D). The values of the individual bars are as follows (given in kcal/mol):
-15.4 ± 3.9 for B1, -18.8 ± 3.9 for B2, -16.9 ± 2.8 for B3, -15.5 ± 4.1 for B4, -20.9 ± 3.0 for D1
and -22.0 ± 2.7 for D2.
(TIFF)
S7 Fig. Overview of the distances between Ile183 of EL2 and Tyr4087.35 of TM7. The calcu-
lated distances between the side chain atoms of Ile183EL2 and Tyr4087.35 for the simulation sys-
tems A and C (A) and B and D (B) are shown. An interaction between these residues is only
present in simulations of the systems D1 and D2.
(TIFF)
S8 Fig. Evolution of distances between the side chains of Arg1323.50 and Asp350 at the sim-
ulation systems C3 to C12. The distances are highly flexible and do not offer a valid answer
whether or not the ionic interaction between these residues is present at simulation system C.
(TIFF)
S1 Table. Overview of all simulation systems used within this study.
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